GOSSGossamer Bio, Inc.
- Market cap
- $58.75M
- as of 2026-10-23
- Latest close
- $9.60
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-14
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Nathan Steven D | Sep 23 | Sep 25 | A · derivative | 10,000 | $10.99 | $109,900 | 10,000 | No | Form 4 |
| Cox Russell J. | Sep 23 | Sep 25 | A · derivative | 10,000 | $10.99 | $109,900 | 10,000 | No | Form 4 |
| Quisel John D | Sep 23 | Sep 25 | A · derivative | 10,000 | $10.99 | $109,900 | 10,000 | No | Form 4 |
| Drynan Skye | Sep 23 | Sep 25 | A · derivative | 10,000 | $10.99 | $109,900 | 10,000 | No | Form 4 |
| Ciongoli Gregory Austin | Sep 23 | Sep 25 | A · derivative | 30,000 | $10.99 | $329,700 | 30,000 | No | Form 4 |
| Daniel Thomas O | Sep 23 | Sep 25 | A · derivative | 10,000 | $10.99 | $109,900 | 10,000 | No | Form 4 |
| Milligan Sandra | Sep 23 | Sep 25 | A · derivative | 10,000 | $10.99 | $109,900 | 10,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Aug 24 | Aug 26 | A · derivative | 166 | $1,000.00 | $166,000 | 166 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Aug 24 | Aug 26 | A · derivative | 5,800,051 | $0.18 | $1,044,009 | 5,800,051 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Aug 24 | Aug 26 | A · derivative | 2,900,026 | $0.18 | $522,005 | 2,900,026 | No | Form 4 |
| Giraudo BryanCOO/CFO | Aug 24 | Aug 26 | A · derivative | 25 | $1,000.00 | $25,000 | 25 | No | Form 4 |
| Giraudo BryanCOO/CFO | Aug 24 | Aug 26 | A · derivative | 5,800,051 | $0.18 | $1,044,009 | 5,800,051 | No | Form 4 |
| Peterson CarynChief Development Officer | Aug 24 | Aug 26 | A · derivative | 5,800,051 | $0.18 | $1,044,009 | 5,800,051 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Aug 24 | Aug 26 | A · derivative | 5,800,051 | $0.18 | $1,044,009 | 5,800,051 | No | Form 4 |
| Cox Russell J. | Jun 4 | Jun 5 | A · derivative | 115,000 | $0.18 | $20,700 | 115,000 | No | Form 4 |
| Daniel Thomas O | Jun 4 | Jun 5 | A · derivative | 115,000 | $0.18 | $20,700 | 115,000 | No | Form 4 |
| Quisel John D | Jun 4 | Jun 5 | A · derivative | 115,000 | $0.18 | $20,700 | 115,000 | No | Form 4 |
| Milligan Sandra | Jun 4 | Jun 5 | A · derivative | 115,000 | $0.18 | $20,700 | 115,000 | No | Form 4 |
| Drynan Skye | Jun 4 | Jun 5 | A · derivative | 115,000 | $0.18 | $20,700 | 115,000 | No | Form 4 |
| Nathan Steven D | Jun 4 | Jun 5 | A · derivative | 115,000 | $0.18 | $20,700 | 115,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 1,680,000 | $2.88 | $4,838,400 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 1,540,000 | $1.13 | $1,740,200 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 1,312,500 | $0.97 | $1,273,125 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 437,500 | $0.84 | $367,500 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 544,500 | $1.21 | $658,845 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 544,500 | $2.16 | $1,176,120 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 650,000 | $11.94 | $7,761,000 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 325,000 | $9.79 | $3,181,750 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 47,000 | $12.10 | $568,700 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | D · derivative | 43,500 | $22.10 | $961,350 | not reported | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 1,680,000 | $0.45 | $756,000 | 1,680,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 1,540,000 | $0.45 | $693,000 | 1,540,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 1,312,500 | $0.45 | $590,625 | 1,312,500 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 437,500 | $0.45 | $196,875 | 437,500 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 544,500 | $0.45 | $245,025 | 544,500 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 544,500 | $0.45 | $245,025 | 544,500 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 650,000 | $0.45 | $292,500 | 650,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 325,000 | $0.45 | $146,250 | 325,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 47,000 | $0.45 | $21,150 | 47,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 19 | Mar 20 | A · derivative | 43,500 | $0.45 | $19,575 | 43,500 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 506,250 | $2.88 | $1,458,000 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 440,000 | $1.13 | $497,200 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 375,000 | $0.97 | $363,750 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 125,000 | $0.84 | $105,000 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 157,500 | $1.21 | $190,575 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 157,500 | $2.16 | $340,200 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 126,667 | $1.36 | $172,267 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 60,000 | $1.36 | $81,600 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 47,667 | $1.36 | $64,827 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | D · derivative | 70,000 | $1.36 | $95,200 | not reported | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 506,250 | $0.45 | $227,813 | 506,250 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 440,000 | $0.45 | $198,000 | 440,000 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 375,000 | $0.45 | $168,750 | 375,000 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 125,000 | $0.45 | $56,250 | 125,000 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 157,500 | $0.45 | $70,875 | 157,500 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 157,500 | $0.45 | $70,875 | 157,500 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 126,667 | $0.45 | $57,000 | 126,667 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 60,000 | $0.45 | $27,000 | 60,000 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 47,667 | $0.45 | $21,450 | 47,667 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 19 | Mar 20 | A · derivative | 70,000 | $0.45 | $31,500 | 70,000 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 693,750 | $2.88 | $1,998,000 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 638,000 | $1.13 | $720,940 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 543,750 | $0.97 | $527,438 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 181,250 | $0.84 | $152,250 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 211,500 | $1.21 | $255,915 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 211,500 | $2.16 | $456,840 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 176,667 | $1.36 | $240,267 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 100,000 | $1.36 | $136,000 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 60,000 | $1.36 | $81,600 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 47,667 | $1.36 | $64,827 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | D · derivative | 96,667 | $1.36 | $131,467 | not reported | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 693,750 | $0.45 | $312,188 | 693,750 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 638,000 | $0.45 | $287,100 | 638,000 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 543,750 | $0.45 | $244,688 | 543,750 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 181,250 | $0.45 | $81,563 | 181,250 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 211,500 | $0.45 | $95,175 | 211,500 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 211,500 | $0.45 | $95,175 | 211,500 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 176,667 | $0.45 | $79,500 | 176,667 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 100,000 | $0.45 | $45,000 | 100,000 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 60,000 | $0.45 | $27,000 | 60,000 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 47,667 | $0.45 | $21,450 | 47,667 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 19 | Mar 20 | A · derivative | 96,667 | $0.45 | $43,500 | 96,667 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 506,250 | $2.88 | $1,458,000 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 440,000 | $1.13 | $497,200 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 375,000 | $0.97 | $363,750 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 125,000 | $0.84 | $105,000 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 157,500 | $1.21 | $190,575 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 157,500 | $2.16 | $340,200 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 126,667 | $1.36 | $172,267 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 21,167 | $1.36 | $28,787 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 18,834 | $1.36 | $25,614 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 22,784 | $1.36 | $30,986 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 9,167 | $1.36 | $12,467 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | D · derivative | 32,334 | $1.36 | $43,974 | not reported | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 506,250 | $0.45 | $227,813 | 506,250 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 440,000 | $0.45 | $198,000 | 440,000 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 375,000 | $0.45 | $168,750 | 375,000 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 125,000 | $0.45 | $56,250 | 125,000 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 157,500 | $0.45 | $70,875 | 157,500 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 157,500 | $0.45 | $70,875 | 157,500 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 126,667 | $0.45 | $57,000 | 126,667 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 21,167 | $0.45 | $9,525 | 21,167 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 18,834 | $0.45 | $8,475 | 18,834 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 22,784 | $0.45 | $10,253 | 22,784 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 9,167 | $0.45 | $4,125 | 9,167 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 19 | Mar 20 | A · derivative | 32,334 | $0.45 | $14,550 | 32,334 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 562,500 | $2.88 | $1,620,000 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 572,000 | $1.13 | $646,360 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 487,500 | $0.97 | $472,875 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 162,500 | $0.84 | $136,500 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 157,500 | $1.21 | $190,575 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 157,500 | $2.16 | $340,200 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 126,667 | $1.36 | $172,267 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 20,000 | $1.36 | $27,200 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 40,000 | $1.36 | $54,400 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 22,784 | $1.36 | $30,986 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 9,167 | $1.36 | $12,467 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | D · derivative | 30,000 | $1.36 | $40,800 | not reported | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 562,500 | $0.45 | $253,125 | 562,500 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 572,000 | $0.45 | $257,400 | 572,000 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 487,500 | $0.45 | $219,375 | 487,500 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 162,500 | $0.45 | $73,125 | 162,500 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 157,500 | $0.45 | $70,875 | 157,500 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 157,500 | $0.45 | $70,875 | 157,500 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 126,667 | $0.45 | $57,000 | 126,667 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 20,000 | $0.45 | $9,000 | 20,000 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 40,000 | $0.45 | $18,000 | 40,000 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 22,784 | $0.45 | $10,253 | 22,784 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 9,167 | $0.45 | $4,125 | 9,167 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 19 | Mar 20 | A · derivative | 30,000 | $0.45 | $13,500 | 30,000 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Mar 19 | Mar 20 | D · derivative | 562,500 | $2.88 | $1,620,000 | not reported | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Mar 19 | Mar 20 | D · derivative | 572,000 | $1.13 | $646,360 | not reported | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Mar 19 | Mar 20 | A · derivative | 562,500 | $0.45 | $253,125 | 562,500 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Mar 19 | Mar 20 | A · derivative | 572,000 | $0.45 | $257,400 | 572,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Jan 2 | Jan 5 | A | 280,000 | $0.00 | $0 | 837,793 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Jan 2 | Jan 5 | A · derivative | 1,680,000 | $2.88 | $4,838,400 | 1,680,000 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Jan 2 | Jan 5 | A | 84,500 | $0.00 | $0 | 814,061 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Jan 2 | Jan 5 | A · derivative | 506,250 | $2.88 | $1,458,000 | 506,250 | No | Form 4 |
| Giraudo BryanCOO/CFO | Jan 2 | Jan 5 | A | 115,750 | $0.00 | $0 | 389,737 | No | Form 4 |
| Giraudo BryanCOO/CFO | Jan 2 | Jan 5 | A · derivative | 693,750 | $2.88 | $1,998,000 | 693,750 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Jan 2 | Jan 5 | A | 84,500 | $0.00 | $0 | 259,333 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Jan 2 | Jan 5 | A · derivative | 506,250 | $2.88 | $1,458,000 | 506,250 | No | Form 4 |
| Aranda RichardChief Medical Officer | Jan 2 | Jan 5 | A | 93,750 | $0.00 | $0 | 463,106 | No | Form 4 |
| Aranda RichardChief Medical Officer | Jan 2 | Jan 5 | A · derivative | 562,500 | $2.88 | $1,620,000 | 562,500 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Jan 2 | Jan 5 | A | 93,750 | $0.00 | $0 | 260,898 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Jan 2 | Jan 5 | A · derivative | 562,500 | $2.88 | $1,620,000 | 562,500 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Oct 1, 2025 | Oct 2, 2025 | A | 437,500 | $0.00 | $0 | 557,793 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Oct 1, 2025 | Oct 2, 2025 | A | 125,000 | $0.00 | $0 | 710,934 | No | Form 4 |
| Giraudo BryanCOO/CFO | Oct 1, 2025 | Oct 2, 2025 | A | 181,250 | $0.00 | $0 | 273,987 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Oct 1, 2025 | Oct 2, 2025 | A | 125,000 | $0.00 | $0 | 174,833 | No | Form 4 |
| Aranda RichardChief Medical Officer | Oct 1, 2025 | Oct 2, 2025 | A | 162,500 | $0.00 | $0 | 369,356 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Oct 1, 2025 | Oct 2, 2025 | A | 162,500 | $0.00 | $0 | 162,500 | No | Form 4 |
| Milligan Sandra | Aug 19, 2025 | Aug 20, 2025 | P | 26,050 | $1.92 | Purchase +$50,016 | 58,050 | No | Form 4 |
| Drynan Skye | Jun 25, 2025 | Jun 26, 2025 | A · derivative | 115,000 | $1.36 | $156,400 | 115,000 | No | Form 4 |
| Milligan Sandra | Jun 25, 2025 | Jun 26, 2025 | A · derivative | 115,000 | $1.36 | $156,400 | 115,000 | No | Form 4 |
| Quisel John D | Jun 25, 2025 | Jun 26, 2025 | A · derivative | 115,000 | $1.36 | $156,400 | 115,000 | No | Form 4 |
| Cox Russell J. | Jun 25, 2025 | Jun 26, 2025 | A · derivative | 115,000 | $1.36 | $156,400 | 115,000 | No | Form 4 |
| Nathan Steven D | Jun 25, 2025 | Jun 26, 2025 | A · derivative | 115,000 | $1.36 | $156,400 | 115,000 | No | Form 4 |
| Daniel Thomas O | Jun 25, 2025 | Jun 26, 2025 | A · derivative | 115,000 | $1.36 | $156,400 | 115,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 1,540,000 | $1.13 | $1,740,200 | 1,540,000 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 638,000 | $1.13 | $720,940 | 638,000 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 572,000 | $1.13 | $646,360 | 572,000 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 572,000 | $1.13 | $646,360 | 572,000 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 440,000 | $1.13 | $497,200 | 440,000 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 440,000 | $1.13 | $497,200 | 440,000 | No | Form 4 |
| Aranda RichardChief Medical Officer | Jun 24, 2024 | Jun 25, 2024 | S | 1,908 | $0.66 | Sale −$1,259 | 196,891 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Jun 21, 2024 | Jun 24, 2024 | P | 372,000 | $0.67 | Purchase +$249,240 | 5,408,073 | No | Form 4 |
| Giraudo BryanCOO/CFO | Jun 18, 2024 | Jun 20, 2024 | P | 100,000 | $0.59 | Purchase +$59,000 | 480,010 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Jun 17, 2024 | Jun 20, 2024 | P | 25,000 | $0.60 | Purchase +$15,000 | 25,000 | No | Form 4 |
| Daniel Thomas O | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 115,000 | $0.60 | $69,000 | 115,000 | No | Form 4 |
| Cox Russell J. | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 115,000 | $0.60 | $69,000 | 115,000 | No | Form 4 |
| Milligan Sandra | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 115,000 | $0.60 | $69,000 | 115,000 | No | Form 4 |
| Quisel John D | Jun 6, 2024 | Jun 6, 2024 | A · derivative | 115,000 | $0.60 | $69,000 | 115,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Mar 27, 2024 | Mar 28, 2024 | S | 23,172 | $1.16 | Sale −$26,880 | 120,293 | No | Form 4 |
| Giraudo BryanCOO/CFO | Mar 27, 2024 | Mar 28, 2024 | S | 6,430 | $1.16 | Sale −$7,459 | 92,737 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Mar 27, 2024 | Mar 28, 2024 | S | 6,430 | $1.16 | Sale −$7,459 | 585,934 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Mar 18, 2024 | Mar 19, 2024 | S | 4,018 | $1.33 | Sale −$5,344 | 49,833 | No | Form 4 |
| Aranda RichardChief Medical Officer | Mar 18, 2024 | Mar 19, 2024 | S | 4,018 | $1.33 | Sale −$5,344 | 198,799 | No | Form 4 |
| Nathan Steven D | Mar 11, 2024 | Mar 12, 2024 | A · derivative | 230,000 | $1.34 | $308,200 | 230,000 | No | Form 4 |
| Drynan Skye | Mar 11, 2024 | Mar 12, 2024 | A · derivative | 230,000 | $1.34 | $308,200 | 230,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 1,312,500 | $0.97 | $1,273,125 | 1,312,500 | No | Form 4 |
| Giraudo BryanCOO/CFO | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 543,750 | $0.97 | $527,438 | 543,750 | No | Form 4 |
| Aranda RichardChief Medical Officer | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 487,500 | $0.97 | $472,875 | 487,500 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 375,000 | $0.97 | $363,750 | 375,000 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Jan 2, 2024 | Jan 4, 2024 | A · derivative | 375,000 | $0.97 | $363,750 | 375,000 | No | Form 4 |
| Smith Robert Paul JRChief Commercial Officer | Dec 4, 2023 | Dec 5, 2023 | A · derivative | 1,500,000 | $0.97 | $1,455,000 | 1,500,000 | No | Form 4 |
| Quisel John D | Nov 28, 2023 | Nov 29, 2023 | A · derivative | 230,000 | $0.69 | $158,700 | 230,000 | No | Form 4 |
| Christian WaageEVP, Tech Ops and Admin | Nov 20, 2023 | Nov 22, 2023 | A · derivative | 125,000 | $0.84 | $105,000 | 125,000 | No | Form 4 |
| Hasnain FaheemPresident & CEO | Nov 20, 2023 | Nov 22, 2023 | A · derivative | 437,500 | $0.84 | $367,500 | 437,500 | No | Form 4 |
| Peterson CarynEVP, Regulatory Affairs | Nov 20, 2023 | Nov 22, 2023 | A · derivative | 125,000 | $0.84 | $105,000 | 125,000 | No | Form 4 |
| Giraudo BryanCOO/CFO | Nov 20, 2023 | Nov 22, 2023 | A · derivative | 181,250 | $0.84 | $152,250 | 181,250 | No | Form 4 |
| Aranda RichardChief Medical Officer | Nov 20, 2023 | Nov 22, 2023 | A · derivative | 162,500 | $0.84 | $136,500 | 162,500 | No | Form 4 |
| Milligan Sandra | Nov 15, 2023 | Nov 17, 2023 | P | 32,000 | $0.79 | Purchase +$25,280 | 32,000 | No | Form 4 |
| Giraudo BryanCOO/CFO | Nov 13, 2023 | Nov 14, 2023 | P | 200,000 | $0.56 | Purchase +$112,000 | 380,010 | No | Form 4 |